Introduction
Inositol-1,4,5-trisphosphate-3-kinase A (InsP 3 Kinase) is an InsP 3 kinase that binds to and bundles actin filaments. Based on this bi-functional property, the protein regulates inositol phosphate signalling as well as actin dynamics [1, 2] . Although physiologically the InsP 3 Kinase is mainly expressed in brain, we and others found that also tumor cells can gain the ability to express InsP 3 Kinase [2] [3] [4] [5] [6] . This re-expression of InsP 3 Kinase occurs by reducing DNA methylation of the itpka promoter or by mutation of the transcriptional repressor RE1-Silencing Transcription factor REST [7] . Our data revealed that in particular lung carcinoma cells showed up-regulated InsP 3 Kinase expression and we found that this upregulation significantly increased the metastatic potential of lung tumor cells [2, 3] . Thus, InsP 3 Kinase is an interesting drug target against lung cancer cells. Since both, the InsP 3 kinase-and the actinbundling-activity of InsP 3 Kinase were found to be essential for the metastasis-promoting effect of InsP 3 Kinase [2] , inhibitors against both activities had to be identified. Although highly potent InsP 3 kinase-inhibitors had been already found, most of these inhibitors were plant polyphenols which inhibit multiple cellular targets and are poorly membrane permeable [8] . Therefore, we performed a high through put screen to identify more specific and membrane-permeable inhibitors against the InsP 3 kinase-activity of InsP 3 Kinase. By screening 34144 chemical compounds, 237 active Biochemical Pharmacology 96 (2015) [143] [144] [145] [146] [147] [148] [149] [150] As ectopic expression of the neuronal inositol-1,4,5-trisphosphate-3-kinase A (InsP 3 Kinase) in tumor cells increases the metastatic potential, InsP 3 Kinase is an interesting target for tumor therapy. Recently, we have identified a membrane-permeable InsP 3 Kinase inhibitor (BAMB-4) exhibiting an IC50-value of 20 mM. Here we characterized a new InsP 3 Kinase inhibitor which shows a 130-fold lower IC50 value (157 AE 57 nM) as compared to BAMB-4. We demonstrate that this nitrophenolic compound, BIP-4, is noncompetitive to ATP but competitive to InsP 3 , thus exhibits a high selectivity for inhibition of InsP 3 Kinase activity. Docking analysis suggested a putative binding mode of this molecule into the InsP 3 Kinase active site. Determination of cellular uptake in lung cancer cells (H1299) revealed that 6% of extracellular BIP-4 is internalized by non-endosomal uptake, showing that BIP-4 is not trapped inside endo/lysosomes but is available to inhibit cellular InsP 3 Kinase activity. Interestingly, we found that BIP-4 mediated inhibition of InsP 3 Kinase activity in the two lung cancer cell lines H1299 and LN4323 inhibited proliferation and adhesion at IC50 values of 3 mM or 2 mM, respectively. InsP 3 Kinase inhibition did not alter ATP-induced calcium signals but significantly reduced the level of Ins(1,3,4,5,6)P 5 . From these data we conclude that the inhibitory effect of BIP-4 on proliferation and adhesion of lung cancer cells does not result from alterations of calcium but from alterations of inositol phosphate signals. In summary, we reveal that inhibition of cellular InsP 3 Kinase by BIP-4 impairs proliferation and adhesion and therefore BIP-4 might be a promising compound to reduce the metastatic potential of lung carcinoma cells. ß 2015 Elsevier Inc. All rights reserved.
compounds were identified of which three substances with highest specificity (inhibition frequency) and best potential membrane permeability (hydrophobicity) were selected. Among these compounds only N-(1,2-benzoaxol-3-yl)-4-methylbenzamid (BAMB-4) proved to be stable after cellular uptake. 
Material and methods

Recombinant expression and purification of InsP 3 Kinase
A C-terminal sequence of 306 amino acids containing the catalytic and calmodulin-binding-domain of InsP 3 Kinase was cloned into the vector pET17b and was recombinantly expressed in E. coli BL21. The protein was enriched by phosphocellulose chromatography and purified by CaM-sepharose affinity chromatography as described in Ref. [10] .
High Throughput Screen (HTRS) for InsP 3 kinase-inhibitors
The primary screen for InsP 3 Cells were maintained at 37 8C/5% CO 2 in a humidified incubator (HERACELL 240i, Thermo Scientific).
Cell proliferation assay
Cells were seeded in 6-well plates (CELLSTAR, Greiner bio-one, Frickenhausen, Germany) in a concentration of 3 Â 10 5 cells per well. After incubation for 24 h at 37 8C, -4) or the diluent acetonitrile (ACN) were added. After further incubation for 24 h cells were trypsinized and counted using CASY Cell Counter (Model DT, Innovatis, Germany).
Adhesion assay
To analyze the effect of BIP-4 on adhesion, cells were seeded in 6-well plates in a concentration of 3 Â 10 5 cells per well. 
Determination of enzyme kinetic parameters
K m value for BIP-4 was determined by measuring InsP 3 Kinase activity by a coupled optical assay) [8] in presence and absence of BIP-4 (1 nM, 10 nM, 50 nM, 100 nM, 200 nM, 500 nM). Eight different measurements were performed with different initial enzyme activities. IC50-values were calculated for each measurement series and mean values AE SEM from the eight measurements were calculated.
To determine the inhibitor type, different ATP (InsP 3 constant) or different InsP 3 (ATP constant) concentrations were employed and V max and K m -values were calculated for non-inhibited and inhibited InsP 3 Kinase. Five to eight different measurements were performed and mean values AE SEM were calculated.
Docking experiments
Molecular docking was carried out using GOLD (Genetic Optimization for Ligand Docking) software using the genetic algorithm (GA) [11] . The structural model for BIP-4 has been obtained with the Ligand Builder routine of COOT [12] , and its geometry optimization and restrains generation with the eLBOW module of Phenix using its AM1 QM method [13] . The BIP-4 molecule was docked into the catalytic site of InsP 3 kinase obtained from the InsP 3 kinase-/InsP 3 /AMPPNP crystal complex structure (pdb code 1w2c). The docking-search area was defined as a 6 Å sphere centred on the InsP 3 molecule. We have performed docking allowing full flexibility of the ligand. Gold default settings were used, performing a maximum of 30 genetic algorithm runs. The default scoring function CHEMPLP was used to score the docking poses. This function uses PLP atom-atom interaction types and ChemScore contributions for values such as hydrogen bonds and internal clash terms [13] .
Determination of cellular BIP-4 uptake by HPLC
H1299 cells were cultured in 10 diameter dishes with 10 ml DMEM/10% FCS to about 90% confluence and 25 mM BIP-4 or ACN were added. After incubation for different times points, the cells were washed five-fold with phosphate saline (PBS). Subsequently, methanol was added, the cells were scraped and transferred into micro tubes. For deficiency control 25 mM BIP-4 was added to untreated cells suspended in methanol. Tubes were incubated for 5 min on the plate shaker (Heidolph, Duomax 1030) and centrifuged for 10 min at 13,000 rpm at 4 8C. Supernatants were collected and the methanol extraction was repeated twice. The three fractions were combined and dried via speed Vac (Christ, Alpha RVC). The lyophilisates were resuspended in 200 ml DMSO.
The concentration of BIP-4 was analysed by High-performance liquid chromatography (HPLC; Agilent 1100 Series). A pre-column from Supelco (Cat# 53504-U) and a C18 reversed phase column (Ascentis Express C18, 3 mm Â 15 cm, Cat# 53816) was used for separation. The methanol extract was diluted 1:1 with a dest. and 50 ml of this dilution was applied to HPLC which was performed isocratically with a flow rate of 0.2 ml/min at 22 8C. 60% acetonitrile/A. dest was used as eluent.
To analyze the concentration of BIP-4 in the culture medium, medium was treated with ACN (1:1), incubated at 4 8C for 1 h to precipitate serum proteins and was centrifuged for 15 min at 13,000 Â g 4 8C. The supernatant (serum-free medium) was 
Measurements of caspase-3 activity to analyze apoptosis
To determine the fraction of apoptotic cells in inhibitor-treated and control cells, activity of caspase-3 was measured using Caspase-Glo3/7 reagent kit purchased from Promega (Madison, WI, USA). H1299 cells were seeded in a 96-well plate (CELLSTAR, Greiner bio-one, Frickenhausen, Germany) in a concentration of 1 Â 10 4 cells. After 24 h, medium was removed and fresh medium containing either 8 mM BIP-4 or ACN (control) was added and incubation was continued for 24 h. Thereafter, the medium was replaced by a solution of 50 ml fresh medium and 50 ml CaspaseGlo 3/7 reagent, cells were frozen for 30 min at À80 8C, mixed with pipette and fluorescence was measured using Safire 2 (Tecan) reader at 485 nm for excitation and 530 nm for emission.
Measurement of cell cycle distribution
H1299 cells were seeded in 10 cm diameter petri dishes purchased from (CELLSTAR, Greiner bio-one, Frickenhausen, Germany) in a concentration of 1. 
Statistics
Significances were analysed by One Way ANOVA or unpaired t-test using Graph Pad Prism.
Results and discussion
BIP-4 is a much more potent InsP 3 Kinase inhibitor than BAMB-4
To identify an InsP 3 Kinase inhibitor with lower IC50 value compared to BIP-4, we tested additional InsP 3 Kinase inhibitors from our library and found that the nitrophenolic compound BIP-4 (Fig. 1A) exhibits the lowest IC50 value: 157 AE 57 nM (Fig. 1B) . In order to predict the specificity for InsP 3 Kinase inhibition, we next analyzed the inhibitor type. Inhibitors competitive to ATP tend to be rather unspecific than inhibitors competitive to InsP 3 because in contrast to the InsP 3 binding region, which is unique among inositol phosphate kinases, the ATP binding site is highly conserved among them and within the protein kinase superfamily [15, 16] .
The inhibitor type of BIP-4 was analyzed by employing different InsP 3 (ATP constant) and different ATP (InsP 3 constant) concentrations and V max and K m for InsP 3 and ATP, respectively, were calculated. We found that V max for ATP was significantly reduced but V max for InsP 3 was not significantly altered in presence of BIP-4 as compared to ACN-treated enzyme. On the other hand, K m -value for ATP was similar between control and inhibited InsP 3 Kinase while K m -value for InsP 3 was 2.5 fold higher in presence of BIP-4 as compared to control sample (Table 1) . From these results we conclude that BIP-4 is non-competitive for ATP but competitive for InsP 3 .
In summary our data show that BIP-4 seems to be a more promising substance to specifically inhibit cellular InsP 3 Kinase than BAMB-4, because it (1) has a 130-fold lower IC-50 value for InsP 3 Kinase inhibition than BAMB-4 and (2) it is non-competitive to ATP and competitive to InsP 3 , thus more specific than the mixed type inhibitor BAMB-4. 
Docking analysis of BIP-4 InsP 3 Kinase interactions
Uptake efficiency of BIP-4 in H1299 cells
Since our aim was to inhibit cellular InsP 3 Kinase in order to partly block the metastatic potential of InsP 3 Kinase, we next examined if lung cancer cells are able to take up BIP-4. This experiment was essential because in contrast to BAMB-4, which has a hydrophobic character and thus is well membrane permeable [9] , the BIP-4 molecule contains three nitro groups, making it more polar. In order to show if H1299 cells are able to take up BIP-4, the cells were incubated with 25 mM BIP-4 and after incubation for 16 h, the substance was extracted with methanol and analyzed by HPLC. As expected, cellular uptake of BIP-4 was much lower than uptake of BAMB-4, the cells internalized only 6% of extracellular BIP-4 (Fig. 3A) . The main amount of BIP-4 remained in the medium (65%) or was bound to serum proteins (30%) when cells were incubated with medium containing 10% FCS (Fig. 3B) . However, in presence of 2% FCS, BIP-4 did not bind to serum proteins (data not shown), showing that retention of BIP-4 to serum proteins depends on the serum concentration.
In conclusion, we demonstrate that H1299 cells are able to take up BIP-4 but to a lower extend then BAMB-4. However, since the IC50-value of BIP-4 is 130-fold lower for InsP 3 kinase inhibition than that of BAMB-4, medium concentrations of about 3 mM should be sufficient to inhibit cellular InsP 3 kinase.
Uptake mechanism of BIP-4
Next, we had to show that after cellular uptake BIP-4 is available to inhibit InsP 3 Kinase activity because many extracellular substances are endocytosed and thus trapped inside endo/ lysosomes [17] .
Since endocytosis is blocked at 4 8C [18], we examined internalization of BIP-4 at 4 8C and at 37 8C. At 4 8C uptake of BIP-4 should be inhibited when cells had taken up the substance by endocytosis. However, uptake of BIP-4 was similar when cells were incubated at 37 8C or 4 8C, showing that BIP-4 was not internalized by endocytosis (Fig. 4A) .
To distinguish between specific and non-specific uptake, the time-dependence of BIP-4 uptake was determined because specific uptake occurs fast (within minutes) and does not increase with time whereas uptake by a nonspecific mechanism is much slower [19] . Uptake of BIP-4 occurs very slowly and increases with time, showing that BIP-4 is internalized by a non-specific uptake mechanism (Fig. 4B) . Based on these data we assume that BIP-4 is internalized by facilitated diffusion through carrier-proteins [17] .
Summarized, our data reveal that BIP-4 is internalized in a nonspecific, non-endocytotic way and thus, not trapped inside endo/ lysosomes. Based on these results we conclude that the inhibitor should be available to inhibit cellular InsP 3 Kinase activity.
Cellular effects of BIP-4
After proving that BIP-4 is available to inhibit cellular Ins 3 Kinase activity, we analysed its effect on different steps of metastasis; adhesion, migration and proliferation. For this approach the two different lung cancer cell lines H1299 and LN4323 were used. Both cell lines were derived from lymph node metastasis, thus are highly malignant.
Our data show that BIP-4 inhibited adhesion and proliferation of H1299 and LN4323 cells with IC50 values of 3 mM or 2 mM.
However, migration of both cell lines was only slightly inhibited at these concentrations (Fig. 5A-C) .
To analyse the mechanism of how BIP-4 inhibits proliferation, cell cycle phases as well as apoptosis of H1299 cells were analyzed after incubation with BIP-4 in comparison to non-treated cells. We found that 6 h after BIP-4 treatment, the fraction of S-phase cells was significantly increased (by 15%; p = 0.0122) and the fraction of G1-phase cells was significantly decreased (by 10%; p = 0.0209) in presence of BIP-4 as compared to control cells (Fig. 6A) . After 24 h of incubation with BIP-4, the fraction of S-phase cells was only slightly (by 8%; p = 0.0944) and not significantly increased in inhibitor treated as compared to control cells (Fig. 6B ), but measurement of apoptosis revealed that the fraction of apoptotic cells was nearly 3-fold increased as compared to controls (Fig. 6C) . Since the fraction of S-phase cells was only significantly increased after six but not after 24 h of incubation with BIP-4, we assume that from S-phase arrest the cells exit into apoptosis. It is, however, very likely that S-phase arrest and induction of apoptosis occurs in parallel [20, 21] because the increase of apoptotic cells in BIP-4-treated cells is much higher than the increase of S-phase cells. Thus, we conclude that BIP-4 decreases proliferation by induction of cell cycle arrest and apoptosis.
In summary our data show that BIP-4 inhibited adhesion and proliferation of H1299 and LN4323 cells with IC50 values of 3 mM or 2 mM, respectively. Since cells only took up 6% of BIP-4 from the medium, the intracellular concentration of BIP-4 is 180 nM or 120 nM, respectively, which is in the range of the IC50 value for InsP 3 Kinase inhibition (157 AE 57 nM). Thus, we conclude that adhesion as well as proliferation is controlled by InsP 3 Kinase activity. Since migration was only slightly inhibited after InsP 3 Kinase inhibition, this cellular process does not seem to be mainly controlled by InsP 3 Kinase activity.
Downstream effects of InsP 3 Kinase inhibition
In order to explain how InsP 3 Kinase activity controls adhesion and migration of lung cancer cells, we analyzed the two signal transduction pathways potentially regulated by InsP 3 Kinase activity; Ins(1,4,5)P 3 -induced calcium release from the endoplasmatic reticulum into the cytosol and inositol phosphate signals. For both analysis the cells were treated with BIP-4 for 18 h and thereafter with ATP to activate PLCb which catalyzes synthesis of Ins(1,4,5)P 3 from Ptd(4,5)P 2 [22] . Measurement of calcium signals after addition of ATP revealed a clear Ins(1,4,5)P 3 -induced calcium signal which persisted for about 200 s (Fig. 7A ). After stimulation with ATP for 90 s we measured the cellular concentration of inositol phosphates and evaluated the concentration of Ins(1,3,4,5,6)P 5 because the product of InsP 3 Kinase activity, Ins(1,3,4,5)P 4 is rapidly metabolized to this more stable InsP 5 isomer.
Our data show that inhibition of InsP 3 Kinase activity did not significantly alter the strength and duration of Ins(1,4,5)P 3 -induced calcium signals in H1299 cells (Fig. 7A) . This result confirms the finding of Dupont and Erneux [23] showing that mainly the Ins(1,4,5)P 3 -5 0 phosphatase controls termination of Ins(1,4,5)P 3 -induced calcium signals [24] . The phosphatase has a ten-fold higher enzyme activity for Ins(1,4,5)P 3 as compared to InsP 3 Kinase [24] which explains why at high Ins(1,4,5)P 3 concentrations after receptor stimulation Ins(1,4,5)P 3 is mainly dephosphorylated. However, in comparison to Ins(1,4,5)P 3 -5 0 phosphatase the affinity of InsP 3 Kinase for Ins(1,4,5)P 3 is tenfold higher indicating that low basal Ins(1,4,5)P 3 levels are controlled by InsP 3 Kinase activity. Indeed, our data show that inhibition of cellular InsP 3 Kinase activity for 18 h significantly reduced the cellular concentration of Ins(1,3,4,5,6)P 5 ( Fig. 7B) , supporting the conclusion that InsP 3 Kinase is required to phosphorylate basal Ins(1,4,5)P 3 , thus to maintain high cellular Ins(1,3,4,5,6)P 5 levels.
In summary our data demonstrate that inhibition of cellular InsP 3 Kinase does not alter Ins(1,4,5)P 3 -induced calcium signals but significantly reduces the concentration of Ins(1,3,4,5,6)P 5 . Based on this result we conclude that InsP 3 Kinase does not regulate stimulation dependent Ins(1,4,5)P 3 -levels but is essentially involved in maintaining high basal cellular levels of Ins(1,3,4,5,6)P 5 . Since inhibition of cellular InsP 3 Kinase significantly impairs proliferation and adhesion of lung tumor cells we strongly assume that maintenance of the cellular Ins(1,3,4,5,6)P 5 concentration is of high importance. However, further studies are necessary to elucidate the precise role of Ins(1,3,4,5,6)P 5 for proliferation and adhesion of tumor cells. 
